BioCentury
ARTICLE | Company News

Thermo Fisher buying gene therapy manufacturer Brammer Bio

March 25, 2019 2:01 PM UTC

Thermo Fisher will pay $1.7 billion to acquire gene and cell therapy contract development and manufacturing company Brammer Bio, giving it vector manufacturing sites in Massachusetts and Florida.

Thermo Fisher Scientific Inc. (NYSE:TMO), which chiefly makes laboratory instruments and equipment, said Brammer Bio (Cambridge, Mass.) is likely to generate $250 million in 2019 revenue...

BCIQ Company Profiles

Thermo Fisher Scientific Inc.